This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| cohort study | |
|---|---|
| Name | Cohort study |
| Type | Observational study |
| Field | Epidemiology, Public health, Medicine |
| Related | Case–control study, Randomized controlled trial, Longitudinal study |
cohort study A cohort study is an observational research design that follows a group of people sharing a defining characteristic over time to assess associations between exposures and outcomes. Originating in nineteenth- and twentieth-century investigations, cohort designs have been foundational in modern Epidemiology and Public health practice, influencing policy at institutions such as the World Health Organization and Centers for Disease Control and Prevention.
A cohort study tracks a defined group (a cohort) to measure incidence of outcomes in relation to prior exposures, distinguishing exposed versus unexposed groups and producing relative risk estimates useful for International Agency for Research on Cancer assessments and guidelines by the National Institutes of Health. Classic cohort work informed landmark findings linked to tobacco use and lung cancer that influenced rulings by the United States Supreme Court and public actions by the Royal Society. Cohort studies range from small community investigations associated with local hospitals like Mayo Clinic to large population registries managed by national agencies such as Statistics Sweden and Public Health England.
Prospective cohort designs enroll participants before outcomes occur, employed in landmark projects at institutions like Framingham Heart Study and the Nurses' Health Study; retrospective (historic) cohorts use existing records from sources such as the Social Security Administration or military archives like the United States Army registers. Birth cohort studies follow individuals born in a specific period—examples include projects coordinated by the National Child Development Study and initiatives associated with the British Medical Journal publishing consortia. Occupational cohorts, such as those linked to the International Agency for Research on Cancer monographs on diesel exhaust, and open cohorts used in surveillance by the European Centre for Disease Prevention and Control also illustrate design variety.
Cohort methodology emphasizes clear exposure definitions, standardized baseline assessment, and systematic follow-up using tools from institutions like the World Health Organization's questionnaires and measurement protocols from the National Institute for Occupational Safety and Health. Data collection sources include medical records from systems like Kaiser Permanente, registry data from agencies such as Cancer Research UK, administrative datasets from ministries of health in countries like Sweden or Denmark, and laboratory measurements coordinated with centers like the Centers for Disease Control and Prevention. Modern cohorts integrate electronic health records, biobanks exemplified by UK Biobank, imaging repositories such as those used by the National Institutes of Health, and linkage with environmental exposure mapping conducted by agencies like the Environmental Protection Agency.
Cohort studies confront selection bias as seen in volunteer samples recruited through organizations like AARP and attrition effects documented in long-term projects by the Framingham Heart Study team. Information bias can arise from differential misclassification when relying on administrative coding systems used by entities such as the National Health Service; validation often requires cross-referencing with registry data from bodies like Eurostat or adjudication committees modeled after protocols from the American Heart Association. Confounding control uses design strategies (restriction, matching) and analytic methods recommended by statisticians at institutions such as Harvard University and Johns Hopkins University, with sensitivity analyses informed by frameworks from the Cochrane Collaboration.
Primary measures include incidence rates, cumulative incidence, relative risk, and attributable risk; survival analyses employ Kaplan–Meier estimators and Cox proportional hazards models developed in statistical work associated with universities like University of Oxford and University of Cambridge. Advanced methods—time-varying covariates, marginal structural models, and competing risks—are applied in large cohorts analyzed by teams at Stanford University and Massachusetts Institute of Technology. Power calculations and sample-size planning often reference guidance from the National Institutes of Health and statistical texts used in courses at Columbia University.
Ethical oversight for cohort studies follows review by institutional review boards such as those at Harvard Medical School and University College London, and must address informed consent, data privacy, and governance structures similar to frameworks promulgated by the World Medical Association and the European Data Protection Board. Longitudinal biobanking and genetic analyses require policies aligning with standards from the Human Genome Organisation and recommendations from ethics committees at institutions like the Wellcome Trust.
Notable cohort investigations include the Framingham Heart Study, the British Doctors Study, the Nurses' Health Study, and population biobanks like UK Biobank; occupational and environmental cohorts have been central to regulatory assessments by the International Agency for Research on Cancer and exposure-response analyses used by the Environmental Protection Agency. Disease-specific cohorts run by institutions such as St Jude Children's Research Hospital and registries administered by Cancer Research UK have informed clinical guidelines endorsed by professional bodies like the American College of Cardiology and Royal College of Physicians. Contemporary cohort consortia—collaborations between centers including Johns Hopkins University, University of California, San Francisco, and Massachusetts General Hospital—enable pooled analyses that shape recommendations from organizations such as the World Health Organization and influence legislation in jurisdictions overseen by the European Commission.